Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the safety and efficacy of intravenous 6β-Naltrexol administered to opiate dependent subjects
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
California Pacific Medical Center Research Institute
NCT02345655 · Opiate Addiction
NCT02867124 · Opiate Addiction
NCT02667210 · Opioid-Related Disorders, Opiate Addiction, and more
NCT02668549 · Opioid-Related Disorders, Opiate Addiction, and more
NCT02667197 · Opioid-Related Disorders, Opiate Addiction, and more
CPMC Addiction & Pharmacology Research Laboratory (APRL)
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions